Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
small cell lung cancer
Pharma
Jazz's lung cancer drug keeps approval despite failed trial
After one failed confirmed trial of Zepzelca, the FDA has found reasons to explain the flop and signed off on two new confirmatory studies.
Angus Liu
Oct 26, 2022 2:54pm
Takeda, Daiichi Sankyo, Dizal, Biden and more—Fierce Pharma Asia
Sep 16, 2022 10:15am
Henlius CEO scouts for US PD-1 partner amid Fosun unit's pivot
Aug 30, 2022 1:30am
AstraZeneca adds caregivers to refreshed note card campaign
Apr 5, 2022 7:15am
Jazz charts new path for Zepzelca after SCLC trial flop
Sep 9, 2021 11:00am
Jazz launches educational site for small cell lung cancer
Jun 18, 2021 4:27am